Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This case report highlights that new onset non-scarring alopecia after allogeneic stem cell transplantation may indicate chronic graft-versus-host disease.

This study found that facial threading decreased skin roughness and improved subjective assessments of skin smoothness and color after three sessions.

This study found that using a topical zinc-thymulin spray on the scalp for more than 6 months was safe and significantly improved hair growth in adults with male pattern baldness, with notable increases in certain hair types and no reported adverse effects.

This article reviews androgenetic alopecia and its genetic and hormonal influences, treatment options like minoxidil and finasteride, and its potential associations with other health conditions, reporting no new clinical results.

This study found that using minoxidil 2% as a mesotherapy injection showed more significant improvement in treating androgenetic alopecia in female patients than topical application.

This paper reviews hidradenitis suppurativa, comparing its clinical and histopathological characteristics to acne, questioning the proposed link to terminal hair follicles, and reports no new results.

This report describes a case of trichostasis spinulosa, a condition with pruritic, black papules on the face caused by keratotic plugs with embedded vellus hairs.

This review outlines the functional anatomy, pathology, and molecular mechanisms of androgenetic alopecia, emphasizing the need for multi-omics approaches to better understand this condition's biology.

This study characterizes the secondary hair follicles in the Lanyu pig, an indigenous breed sharing similarities with human vellus hair follicles, suggesting its relevance as a model for researching hair follicle-mediated skin regeneration and enhancing translation to human wound healing.

Higher fluence low-level laser therapy effectively promotes hair growth in androgenetic alopecia, with varying effects based on sex.

This study reported that both AGA and SD in Caucasian male patients showed overlapping histopathological features with FAPD, particularly perifollicular fibrosis and inflammation, complicating diagnosis.

In this study, researchers found significant associations between trichoscopic features and the severity of androgenetic alopecia in Korean participants, suggesting trichoscopy as a useful tool for early detection and monitoring by identifying indicators like vellus hairs and follicular unit changes.

This study evaluated the use of Jet Peel technology, a non-invasive hydroporation method, in treating androgenetic and telogen effluvium alopecia, finding improvements in hair growth and thickness, and a reduction in associated scalp conditions.

This study evaluated salmon-derived exosomes combined with microneedling as a treatment for androgenetic alopecia, reporting significant improvements in hair density, follicular health, and scalp microenvironment, with no serious adverse events observed in the 20 patients after 12 weeks.

This study reported that microneedle-assisted delivery of PEGylated recombinant human fusion collagen significantly improved hair regrowth and density in an androgenetic alopecia mouse model and in a small clinical trial with AGA patients, suggesting potential efficacy and safety for this treatment approach.

This study found that hair mesotherapy containing biomimetic peptides, vitamins, and micronutrients significantly improved hair parameters in patients with androgenetic alopecia and was well-tolerated over an 8-session treatment period.

This review discusses the psychosocial impact and potential endocrine implications of androgenetic alopecia, particularly noting a moderate impairment in quality of life, but it reports no new clinical results.

In this prospective study, 15 patients with patchy alopecia areata treated with intralesional methotrexate every two weeks showed a significant improvement in hair regrowth and reduction in lesion severity, with changes linked to decreased tissue levels of TNF-α.

This study found trichoscopy to be a reliable non-invasive method for diagnosing various forms of alopecia, aiding in clinical management and reducing the need for biopsies in a hospital-based setting with 90 patients, including those with uncertain diagnoses.

In this prospective study, patients with patchy alopecia areata showed significant dermoscopic improvement after three months of topical corticosteroid treatment, with a marked decrease in activity signs and increase in regrowth features.

In this study, researchers characterized the clinical features of ophiasis, an uncommon type of alopecia areata, and proposed a new subtype classification that may help predict treatment response and guide management, noting that ophiasis generally has a chronic and refractory nature.

This case report highlights two instances of alopecia areata, demonstrating diverse presentations, and suggests upadacitinib as a promising treatment option, resulting in hair regrowth within 3–6 months, without worsening sarcoidosis-related skin lesions.

In this study, microneedle-assisted delivery of polyglutamate significantly improved hair parameters, scalp symptoms, and quality of life in androgenetic alopecia patients, with no serious adverse reactions reported.

This study found that a proprietary saw palmetto extract significantly improved hair growth in men and women with self-perceived thinning hair over a 6-month period, outperforming placebo on key hair growth parameters without any treatment-related adverse events.

This study found that a family history of androgenetic alopecia and specific trichoscopic features are key factors in predicting female pattern hair loss, and the developed nomogram model may help improve disease management by assessing these risks.

This clinical trial conducted at Zagazig University found that minoxidil mesotherapy achieved more significant improvements in alopecia grade, hair thickness, and terminal hair count compared to PRP in adults with androgenetic alopecia, with higher patient satisfaction and less pain reported in the minoxidil group.

In this study, both finasteride and dutasteride were effective for androgenetic alopecia, but dutasteride significantly improved hair density more than finasteride and had a comparable safety profile among men treated at an Indian center.

This article discusses Trikostazis spinuloza (TS), a dermatological condition often misdiagnosed, and reviews its demographic, clinical, and dermoscopic features, but reports no new clinical results.

This study reported that Cosmerna ARI significantly improved androgenetic alopecia in Europeans over a 6-month period compared to a placebo, according to a double-blind, randomized, placebo-controlled clinical trial.

This study found that a proprietary saw palmetto (Serenoa repens) extract significantly increased hair growth and reduced hair shedding in men and women with self-perceived thinning hair over a 90-day period, compared to placebo, without reported adverse events.